TCL Archive NCI Plans to Expand R01 Grant Funding By$48 Million, Increase Other Grants Also February 16, 1996
TCL Archive Secondary AML In High-Dose Chemo Trial Cause For Careful Monitoring, NCI Says August 19, 1994
TCL Archive Cytogen Corp.’s Imaging Agent ProstaScint Added to NCCN Prostate Cancer Guidelines. March 31, 2000